Close
A pharmaceutical company stopped using Microsoft's Copilot AI tool due to high cost and low value. The company found the AI tool comparable to middle school presentations, leading to the cancellation of the deal. Microsoft is considering repackaging 365 licenses to better monetize AI features amid record capex.
The CIO of the pharmaceutical company expressed dissatisfaction with the AI tools, stating they were not worth the extra cost. The company paid extra for 500 employees to use Office 365 Copilot but later decided to cancel the upgrade. Microsoft's AI investments and the challenge of creating value for corporate customers are highlighted in this scenario.
Business Insider 14month
Barron's on MSN.com 9month
The Washington Post on MSN.com 9month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.
Log in
Sign Up
AI Tools - Popular
AI Tools - Categories
GPTs - Categories
AI for Jobs
